Use of isoxazolin-3-one derivatives as antidepressants

Details Use of isoxazolin-3-one derivatives as antidepressants Use of isoxazolin-3-one derivatives as antidepressants

1993-01-29

1993-11-16

Waddell, Frederick E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

5142372, 5142255, 5142265, 5142315, 5142322, 5142332, 5142338, 5142355, 5142375, 514364, 514378, A61K 31535, A61K 3154, A61K 3141, A61K 3142

Patent

active

052624137

ABSTRACT:
A method of treating depression comprising administering to a patient an effective amount of a compound of the formula (Ib): ##STR1## wherein R.sup.1b is hydrogen, halogen, C.sub.1 -C.sub.4 alkyl, C.sub.2 -C.sub.4 alkenyl, C.sub.2 -C.sub.4 alkynyl, an unsubstituted benzyl group, a substituted benzyl having at least one substitutent (b) selected from the group consisting of C.sub.1 -C.sub.3 alkyl, C.sub.1 -C.sub.3 alkoxy, hydroxy, halogen, nitro, amino and C.sub.2 -C.sub.4 aliphatic carboxylic acylamino; unsubstituted phenyl or a substituted phenyl having at least one substitutent (b); R.sup.2b is hydrogen, C.sub.1 -C.sub.4 alkyl, unsubstituted phenyl, substituted phenyl having at least one substitutent (b), unsubstituted 5- or 6- membered heterocyclic having an oxygen, sulfur or nitrogen as a heteroatom, or substituted 5- or 6- membered heterocyclic having an oxygen, sulfur or nitrogen as a heteroatom and having at least one substitutent (b); and R.sup.3b and R.sup.4b are the same or different and each is hydrogen, C.sub.1 -C.sub.4 alkyl, unsubstituted benzyl, substituted benzyl having at least one substituent (b), unsubstituted phenyl, or substituted phenyl having at least one substitutent (b); or R.sup.3b, R.sup.4b and the nitrogen atom to which they are attached together represent an alicyclic amino group having a total of 5 or 6 ring atoms, or which one ring atom is the nitrogen atom and one ring atom is optionally an additional heteroatom selected from the group consisting of nitrogen, oxygen and sulfur, the alicyclic amino group being unsubstituted or, where there is an additional nitrogen heteroatom, the alicyclic amino group having a C.sub.1 -C.sub.3 alkyl substitutent on the additional nitrogen heteroatom; or a pharmacologically acceptable acid addition salt thereof.

REFERENCES:
patent: 4505921 (1985-03-01), Beregi et al.
patent: 4579860 (1986-04-01), Tomita et al.
patent: 4849441 (1989-07-01), Okazaki et al.
patent: 4863948 (1989-09-01), Arrowsmith et al.
Patent Abstracts of Japan, vol. 12, No. 467 (C-550)[3314], Dec. 7, 1988 of JP-A-63-188625 (Mitsui Toatsu Chem. Inc.) Apr. 8, 1988, Japan.
Patent Abstracts of Japan, vol. 5, No. 89 (C-58)[761], Jun. 1981 of JP-A-56 34 674 (Sankyo K.K.), Jun. 4, 1981; Japan.
Patent Abstracts of Japan, vol. 6, No. 90 (C-104)[1968], May 27, 1982 of JP-A-57 21 377 (Shinogi Seiyaku K.K.) Apr. 2, 1982; Japan.

Affiliated with

Also associated with

Rating

Use of isoxazolin-3-one derivatives as antidepressants does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of isoxazolin-3-one derivatives as antidepressants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of isoxazolin-3-one derivatives as antidepressants will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-22722